German battery pioneer closes Series A financing round: 60 million euros for Customcells
mehr
Ergebnis der Suchanfrage nach celle
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
630 Treffer
- 3
Rosberg X Racing and Extreme E join forces with Allianz, Life Terra and the MEDSEA Foundation to restore wildfire-affected area in Sardinia
Ein Dokumentmehr What are the benefits of drinking lemon juice on an empty stomach to our body?
mehrVectorBuilder vann första pris i stor innovationstävling
Chicago, IL (ots) - --News Direct-- VectorBuilder Inc. - en global ledare inom genleveransteknik - meddelade att deras FoU- och tillverkningscenter i Guangzhou vann mästerskapet i sjunde globala tävlingen i innovation och företagande, som hölls i "Chuangke" Hangzhou, Kina. Denna inflytelserika och mycket konkurrensdrivna tävling är en av de största i Kina och täcker företag i tillväxtstadiet inom alla ...
mehrTechnische Universität München
Why are overweight people more susceptible to illness?
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22778 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/news-and-events/all-news/press-releases/details/warum-bekommen-uebergewichtige-menschen-haeufiger-erkrankungen Picture: https://mediatum.ub.tum.de/1612044 NEWS RELEASE Why are overweight people more susceptible to illness? Size of fat cells can cause ...
mehrPR: LAMILUX receives Architects' Darling Award 2022 Silver
Ein DokumentmehrTechnische Universität München
Nanoswitches for tumor targeting
TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de Video: https://www.youtube.com/watch?v=_xXV0mCke1g NEWS RELEASE Nanoswitches for tumor targeting TUM spin-off Plectonic develops antibody-based immunotherapies Plectonic Biotech, a spin-off of the Technical University of Munich (TUM), has developed a nanoswitch that binds immune cells to tumor cells. The goal is to facilitate the development of ...
mehrHearing loss company Acousia Therapeutics to present data for lead candidates ACOU085 & ACOU082 at ARO 2023 MidWinter Meeting February 11–15
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, and its partners from the Translational Hearing Research Group at the Tübingen Hearing Research Center (Department of Otolaryngology, Head and Neck Surgery, University of Tübingen), will present data on its lead candidates — clinical stage ACOU085 and late ...
mehrTechnische Universität München
Tumors: forecasting the risks of brain surgery
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 18198 - email: presse@tum.de - web: www.tum.de This text on the web: http://go.tum.de/619311 Pictures: http://go.tum.de/010709 - http://go.tum.de/959985 - http://go.tum.de/098359 - http://go.tum.de/754050 - http://go.tum.de/109729 Accurately predicting possible post-surgical effects on speech Tumors: forecasting the risks of brain surgery ...
mehrTechnische Universität München
Molecular monitoring of RNA regulation
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10808 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/news-and-events/all-news/press-releases/details/molecular-monitoring-of-rna-regulation Pictures: https://mediatum.ub.tum.de/1691366 NEWS RELEASE Molecular monitoring of RNA regulation New biological tool for tracking cellular processes The better we ...
mehrBattery cell manufacturer CUSTOMCELLS massively expands development capacities
mehrTechnische Universität München
Quantum technology for cancer imaging
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10808 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/news-and-events/all-news/press-releases/details/quantum-technology-for-cancer-imaging NEWS RELEASE Quantum technology for cancer imaging Applied quantum mechanics in medicine Tracing the metabolism of tumor cells using magnetic resonance imaging (MRI) ...
mehrStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research
mehrTechnische Universität München
Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid aggregates
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22779 - email: presse@tum.de - web: www.tum.de Image download: https://mediatum.ub.tum.de/652209?show_id=1691364 NEWS RELEASE Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid ...
mehrCUSTOMCELLS publishes future theses for Germany's battery industry
mehrThe citrus season is starting / The best way to prepare your body for the cold days
Madrid, Spain (ots) - Hot summer days are gone. With the arrival of cold weather there is nothing better than preparing our body to resist the winter with an iron health The nutritional properties of citrus fruits, with their high antioxidant capacity and Vitamin C content, are perfect for keeping our defences up Their characteristics are perfect to meet the ...
mehrKlinik für Prostata-Therapie Heidelberg
Focal therapy for prostate cancer: Reliable diagnosis leads to gentle treatment
mehrCellforce Group lays foundation for modern, sustainable battery production in Europe
mehrType 1 diabetes: New findings on the development of the autoimmune disease in children
mehrSwitching tracks: Changing the trafficking of the glucagon receptor in the liver regulates its metabolic signaling
mehrbenfovir AG has reached another milestone by completing the first part of the Phase 1 trial testing transketolase inhibitor / benfo-oxythiamine (B-OT)
Darmstadt (ots) - benfovir AG, a German pharmaceutical company focused on developing small molecules against viral infections such as SARS-CoV-2, dengue and herpes virus, today announced that the first part of the Phase 1 clinical trial (BV-01-101/ EudraCT Number: 2021-005616-60.) designed to evaluate the safety, ...
mehrLandscape of molecular contacts: How the coronavirus SARS-CoV-2 communicates with human cells
mehrSolid-state battery with salt instead of lithium - Interview
Ein DokumentmehrCellforce Group and Dürr AG successfully establish joint mass production process for electrode coating
mehr10 years of CUSTOMCELLS: Battery cell specialist ready for the next phase of growth
mehrTechnische Universität München
Improved monitoring of silicone implants
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10808 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/aktuelles/alle-meldungen/pressemitteilungen/details/verbessertes-monitoring-von-silikonimplantaten Pictures: https://mediatum.ub.tum.de/1687409 NEWS RELEASE Improved monitoring of silicone implants New algorithm for clinical MRI scanners makes breast ...
mehrAzotic registers Encera™ systemic nitrogen fixing biological in European Union
mehr- 2
PRESS RELEASE: cellcentric and MAHLE cooperate in the supply of fuel cell components
mehr European Society for Medical Oncology (ESMO)
ESMO 2022 - Great oaks grow from small acorns: oncology is committed to doing its part for sustainability
Paris (ots) - At ESMO 2022, 9-13 September, Paris, France, the premier cancer congress in Europe, which has gathered 28k participants from 167 countries, many discussions will be around sustainability, prevention and novel approaches which could soon become a reality in the clinic. - Late-breaking results elucidate ...
mehr- 4
PRESS RELEASE: MAHLE is focusing increasingly on renewable energy
mehr
Vorherige12345678910Nächste